Patients on a waiting list for a corneal transplant or who’s suffering from chronic pain will benefit from the Israeli developed contact lens that are now entering the market.
By KATIE BEITER, THE MEDIA LINE
The FDA has approved a new therapeutic contact lens that will help treat corneal edema, a common eye condition in adults that causes swelling, a build-up of fluid, blurred vision, haziness and scarring. EyeYon, the Israeli company responsible for this development, created these special lenses in an effort to increase the amount of time eye drops can remain in the eye in order to help alleviate symptoms of the condition which is common after cataract and corneal transplant surgeries. Continue Reading »









